Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-05-20 12:10 CEST (UTC+2h)
 

Pathway for Softgel vs Tablet Comparison [Design Issues]

posted by jag009 - NJ, 2018-05-18 16:33  - Posting: # 18786
Views: 55

Hi,

» However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Have you read this guidance? FDA

John

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
18,268 posts in 3,882 threads, 1,162 registered users;
12 users online (0 registered, 12 guests).

Power. That which statisticians are always calculating
but never have.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed